Coronavirus disease 2019 (COVID-19) has become a global pandemic. Currently, SARS-CoV-2 live virus-associated experiments need to be handled in biosafety level 3 (BSL-3) facilities. Previously, researchers had successfully established an HIV-based, pseudotyped virus system for studies on MERS-CoV and Ebola virus. Using the pseudotyped virus system, viral entry associated research, e.g., neutralization assays and in vitro pharmacodynamics, can thus be carried out in the BSL-2 facilities.
In this study, the authors have developed a pseudotyped SARS-CoV-2 system that efficiently operates in a BSL-2 facility. With transfection of two plasmids into HEK293T cells, the authors developed an HIV-1 core-based pseudotyped virus consisting of SARS-CoV-2 spike protein and found Huh7.5 cell line suitable for analysis of the pseudotyped SARS-CoV-2 system. The authors used the Convalescent serum from 11 COVID-19 patients to compare the results of SARS-CoV-2 live-virus microneutralization and the pseudotyped SARS-CoV-2 system and notice a significant correlation between the results obtained by the two methods.
The pseudotyped SARS-CoV-2 system, developed in this study, seems highly reliable for conducting the SARS-CoV-2 viral entry associated research in a BSL-2 facility. The system is suitable for high-throughput analysis and R&D of vaccines and drugs.
Explore further
Provided by Compuscript Ltd
Citation: Development and effectiveness of pseudotyped SARS-CoV-2 system (2021, December 6) retrieved 6 December 2021 from https://medicalxpress.com/news/2021-12-effectiveness-pseudotyped-sars-cov-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
https://news.google.com/__i/rss/rd/articles/CBMiT2h0dHBzOi8vbWVkaWNhbHhwcmVzcy5jb20vbmV3cy8yMDIxLTEyLWVmZmVjdGl2ZW5lc3MtcHNldWRvdHlwZWQtc2Fycy1jb3YtLmh0bWzSAU5odHRwczovL21lZGljYWx4cHJlc3MuY29tL25ld3MvMjAyMS0xMi1lZmZlY3RpdmVuZXNzLXBzZXVkb3R5cGVkLXNhcnMtY292LS5hbXA?oc=5
2021-12-06 14:41:29Z
1067888340
Bagikan Berita Ini
0 Response to "Development and effectiveness of pseudotyped SARS-CoV-2 system - Medical Xpress"
Post a Comment